Bank of Montreal Can lowered its position in shares of The Procter & Gamble Company (NYSE:PG - Free Report) by 10.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,020,735 shares of the company's stock after selling 479,057 shares during the period. Bank of Montreal Can owned about 0.17% of Procter & Gamble worth $674,076,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of the company. Sumitomo Mitsui Financial Group Inc. increased its holdings in Procter & Gamble by 0.9% in the 4th quarter. Sumitomo Mitsui Financial Group Inc. now owns 19,993 shares of the company's stock worth $3,352,000 after buying an additional 180 shares in the last quarter. Polymer Capital Management US LLC purchased a new stake in Procter & Gamble in the fourth quarter worth about $972,000. Cerity Partners LLC boosted its position in shares of Procter & Gamble by 1.3% in the fourth quarter. Cerity Partners LLC now owns 6,439,118 shares of the company's stock worth $1,080,356,000 after purchasing an additional 82,898 shares during the period. Sierra Summit Advisors LLC purchased a new stake in shares of Procter & Gamble during the fourth quarter worth about $845,000. Finally, Ritter Daniher Financial Advisory LLC DE increased its holdings in Procter & Gamble by 7.0% in the 4th quarter. Ritter Daniher Financial Advisory LLC DE now owns 72,978 shares of the company's stock valued at $12,235,000 after acquiring an additional 4,752 shares during the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Procter & Gamble Price Performance
PG opened at $163.73 on Monday. The company has a quick ratio of 0.55, a current ratio of 0.76 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a 12-month low of $153.52 and a 12-month high of $180.43. The stock has a fifty day moving average of $169.17 and a 200-day moving average of $169.12. The firm has a market capitalization of $383.92 billion, a P/E ratio of 26.07, a PEG ratio of 3.76 and a beta of 0.43.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Wednesday, January 22nd. The company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.86 by $0.02. The firm had revenue of $21.88 billion for the quarter, compared to the consensus estimate of $21.66 billion. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. The business's quarterly revenue was up 2.1% on a year-over-year basis. During the same period in the prior year, the business posted $1.84 earnings per share. Equities analysts forecast that The Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, February 18th. Shareholders of record on Friday, January 24th were given a $1.0065 dividend. The ex-dividend date of this dividend was Friday, January 24th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.46%. Procter & Gamble's dividend payout ratio is currently 64.01%.
Insiders Place Their Bets
In related news, insider Marc S. Pritchard sold 90,450 shares of the firm's stock in a transaction that occurred on Thursday, January 23rd. The shares were sold at an average price of $163.84, for a total value of $14,819,328.00. Following the completion of the sale, the insider now owns 172,814 shares of the company's stock, valued at $28,313,845.76. This trade represents a 34.36 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Gary A. Coombe sold 35,000 shares of Procter & Gamble stock in a transaction on Friday, February 28th. The stock was sold at an average price of $173.68, for a total transaction of $6,078,800.00. Following the sale, the chief executive officer now directly owns 22,051 shares of the company's stock, valued at $3,829,817.68. This represents a 61.35 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 143,450 shares of company stock worth $23,988,008 over the last 90 days. Corporate insiders own 0.18% of the company's stock.
Analyst Upgrades and Downgrades
Several research analysts have commented on PG shares. UBS Group reaffirmed a "buy" rating on shares of Procter & Gamble in a research note on Monday, February 10th. Royal Bank of Canada reissued a "sector perform" rating and issued a $164.00 price target on shares of Procter & Gamble in a research report on Thursday, January 23rd. Stifel Nicolaus raised their price target on Procter & Gamble from $161.00 to $165.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. Barclays reiterated an "equal weight" rating on shares of Procter & Gamble in a research note on Thursday, March 27th. Finally, DA Davidson restated a "buy" rating and issued a $209.00 price objective on shares of Procter & Gamble in a report on Thursday, January 23rd. Seven equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and three have assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $182.00.
Read Our Latest Stock Analysis on PG
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report